Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Atkins

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of the Royal Society of Medicine|July 4, 2007
Cost to the NHS of Roche oncology treatmentsMichael Atkins
Seminars in Oncology|November 25, 2015
Immunotherapy Combinations With Checkpoint Inhibitors in Metastatic Melanoma: Current Approaches and Future DirectionsMichael Atkins
The New England Journal of Medicine|February 17, 2006
Autoimmunity and immunotherapy for cancerHenry Koon, Michael Atkins
Physical Review Letters|February 19, 2013
Bounds on the nonminimal coupling of the Higgs boson to gravityMichael Atkins, Xavier Calmet
International Immunology|October 18, 2014
Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodiesGeorge K Philips, Michael Atkins
Current Urology Reports|February 17, 2006
Designing clinical trials for kidney cancer based on newly developed prognostic and predictive toolsDaniel Cho, David McDermott, Michael Atkins
The New England Journal of Medicine|September 3, 2025
Malnutrition in Older AdultsHeyue Du, Michael Atkins, Robert Joyner
BJU International|April 24, 2008
Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapySabina Signoretti, Meredith Regan, Michael Atkins
Clinical Genitourinary Cancer|June 8, 2007
What is standard initial systemic therapy in metastatic renal cell carcinoma?Brian I Rini, David McDermott, Michael Atkins
Nature Reviews. Drug Discovery|April 22, 2006
Sunitinib maleateMichael Atkins, Carole A Jones, Peter Kirkpatrick
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of the Royal Society of Medicine|July 4, 2007
Cost to the NHS of Roche oncology treatmentsMichael Atkins
Seminars in Oncology|November 25, 2015
Immunotherapy Combinations With Checkpoint Inhibitors in Metastatic Melanoma: Current Approaches and Future DirectionsMichael Atkins
The New England Journal of Medicine|February 17, 2006
Autoimmunity and immunotherapy for cancerHenry Koon, Michael Atkins
Physical Review Letters|February 19, 2013
Bounds on the nonminimal coupling of the Higgs boson to gravityMichael Atkins, Xavier Calmet
International Immunology|October 18, 2014
Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodiesGeorge K Philips, Michael Atkins
Current Urology Reports|February 17, 2006
Designing clinical trials for kidney cancer based on newly developed prognostic and predictive toolsDaniel Cho, David McDermott, Michael Atkins
The New England Journal of Medicine|September 3, 2025
Malnutrition in Older AdultsHeyue Du, Michael Atkins, Robert Joyner
BJU International|April 24, 2008
Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapySabina Signoretti, Meredith Regan, Michael Atkins
Clinical Genitourinary Cancer|June 8, 2007
What is standard initial systemic therapy in metastatic renal cell carcinoma?Brian I Rini, David McDermott, Michael Atkins
Nature Reviews. Drug Discovery|April 22, 2006
Sunitinib maleateMichael Atkins, Carole A Jones, Peter Kirkpatrick
Pageof 6